Becton Dickinson said on Wednesday its board has authorized a plan to separate its life sciences unit as the medical device maker aims to focus on its core business.
As Moderna maps out a more cautious future amid lower-than-expected sales of its current products, the company is bolstering ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
2d
A global pharmaceutical company partnered with DelveInsight to create a robust and simplified solution enabling its top ...
In a report released today, Falko Friedrichs from Deutsche Bank maintained a Buy rating on Merck KGaA (0O14 – Research Report), with a price ...
Manas AI, a full-stack, AI-driven company focused on discovering and advancing next generation medicines, launched today. By leveraging its ...
The CEO of Germany's Merck KGaA said a recovery in sales growth at its existing business means it can take a cautious ...
13d
The global gene transfer technologies market, valued at US$3.63 billion in 2023, is forecasted to grow at a robust CAGR of ...
In the pursuit of the extraordinary, the novel, and the unexpected, science and math at RIT blends a passion for research, the practical application of theory, and the active pursuit of new ...
Nitat Termmee / Getty Images While you should enjoy everything life has to offer, it’s important to plan for what will happen when you die. If you have dependents who rely on your income ...
The company (Upstate) was acquired by Serologicals Corp in 2004 for $205 million which became a subsidiary of Millipore Corp which was acquired by Merck KGaA in 2010 ... Arthur (2019) Life Science ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback